[{"address1": "665 Stockton Drive", "address2": "Suite 300", "city": "Exton", "state": "PA", "zip": "19341", "country": "United States", "phone": "610 321 3700", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01 that targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product candidate for the treatment of SARS-CoV-2 infections and COVID-19. The company was incorporated in 2006 and is headquartered in Exton, Pennsylvania.", "fullTimeEmployees": 37, "companyOfficers": [{"maxAge": 1, "name": "Ms. Corleen M. Roche", "age": 56, "title": "Consultant", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": 633053, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 62, "title": "President, CEO & Chairman", "yearBorn": 1961, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott K. Dessain M.D., Ph.D.", "title": "Co-founder & Chairman of the Scientific Advisory Board", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 33, "title": "Interim CFO & Senior VP of Operations", "yearBorn": 1990, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Lapetina", "title": "Principal Accounting Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philip  Roberts", "title": "Chief Technical Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 43, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 50, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 443432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruce  Turner M.D., Ph.D.", "age": 60, "title": "Chief Strategy Officer", "yearBorn": 1963, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "title": "Chief Medical Officer", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1704067200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 16.4, "open": 16.48, "dayLow": 16.27, "dayHigh": 17.735, "regularMarketPreviousClose": 16.4, "regularMarketOpen": 16.48, "regularMarketDayLow": 16.27, "regularMarketDayHigh": 17.735, "beta": 1.536, "forwardPE": -15.747747, "volume": 699461, "regularMarketVolume": 699461, "averageVolume": 259666, "averageVolume10days": 538390, "averageDailyVolume10Day": 538390, "bid": 17.07, "ask": 17.48, "bidSize": 1300, "askSize": 900, "marketCap": 787096384, "fiftyTwoWeekLow": 4.04, "fiftyTwoWeekHigh": 17.735, "priceToSalesTrailing12Months": 77.22688, "fiftyDayAverage": 9.876, "twoHundredDayAverage": 7.620625, "currency": "USD", "enterpriseValue": 656626752, "profitMargins": -2.15443, "floatShares": 25578514, "sharesOutstanding": 45028400, "sharesShort": 1986829, "sharesShortPriorMonth": 678116, "sharesShortPreviousMonthDate": 1702598400, "dateShortInterest": 1705017600, "sharesPercentSharesOut": 0.044099998, "heldPercentInsiders": 0.25287, "heldPercentInstitutions": 0.2374, "shortRatio": 5.38, "shortPercentOfFloat": 0.045700002, "impliedSharesOutstanding": 45028400, "bookValue": 0.498, "priceToBook": 35.100403, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -21958000, "trailingEps": -1.8, "forwardEps": -1.11, "enterpriseToRevenue": 64.426, "enterpriseToEbitda": -29.494, "52WeekChange": 2.196881, "SandP52WeekChange": 0.21733451, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "IMNM", "underlyingSymbol": "IMNM", "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "firstTradeDateEpochUtc": 1601645400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "c2147e86-3bc9-3a00-bf6a-53fc4499717d", "messageBoardId": "finmb_108518404", "gmtOffSetMilliseconds": -18000000, "currentPrice": 17.48, "targetHighPrice": 19.0, "targetLowPrice": 19.0, "targetMeanPrice": 19.0, "targetMedianPrice": 19.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 1, "totalCash": 90641000, "totalCashPerShare": 2.121, "ebitda": -22263000, "totalDebt": 350000, "quickRatio": 3.922, "currentRatio": 3.955, "totalRevenue": 10192000, "debtToEquity": 5.76, "revenuePerShare": 0.837, "returnOnAssets": -0.22900999, "returnOnEquity": -1.5060401, "freeCashflow": 8027000, "operatingCashflow": 3208000, "grossMargins": 1.5467, "ebitdaMargins": -2.18436, "operatingMargins": -1.29958, "financialCurrency": "USD", "trailingPegRatio": null}]